March 17, 2009American Journal of Psychiatry
Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome
Key result
Treatment-resistant depression is associated with a particularly high risk of mortality or cardiac morbidity in patients following acute coronary syndrome.
Why the study?
Is treatment-resistant depression associated with increased mortality or cardiac morbidity in patients following acute coronary syndrome?
Population
Patients with coronary heart disease, specifically following acute coronary syndrome
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May flag high-risk post-ACS patients; leaves open whether treating resistant depression improves outcomes.
Structured PICO
Is treatment-resistant depression associated with increased mortality or cardiac morbidity in patients following acute coronary syndrome?
P
Population
Patients with coronary heart disease, specifically following acute coronary syndrome
E
Exposure
Treatment-resistant depression (exposure)
O
Outcome
Mortality or cardiac morbidityhard clinical
This review highlights that treatment-resistant depression is a significant risk factor for mortality and cardiac morbidity post-ACS, emphasizing the need for better depression management in this population.
Cite This Study
Carney et al. (2009) conducted a review in Treatment-resistant depression after acute coronary syndrome. Treatment-resistant depression was evaluated on Mortality or cardiac morbidity. Treatment-resistant depression is associated with a particularly high risk of mortality or cardiac morbidity in patients following acute coronary syndrome.